4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000899243-21-031103
Chief Scientific Officer acquired 162,137 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Aguilar-Cordova Estuardo · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-07-29 | Conversion : show line 1 in the form | +162,137 | 1,015,923 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-07-29 | Conversion : show line 2 in the form Series B Preferred Stock | −398,519 | 0 | D |
Loading xslF345X03/doc4.xml…